Individuals with T2D and obesity after RYGB presented with increased serum FGF-19 levels (p = 0.024) and decreased total bile acid (p = 0.01) and FGF-21 levels (p = 0.005). This evidence concerns the gene FGF21 and obesity due to melanocortin 4 receptor deficiency.